PubMed Health⌕ Search

PubMed · 2797015

[Mast cells in ulcerative colitis].

Abstract

Authors have studied the changes in number and electronmicroscopic appearances of mast cells in the mucosa of large intestine of patients suffering from colitis ulcerosa either in its active or remission period. Counting of cells was performed in osmium-fixed, semithin, Giemsa-stained sections to avoid variations in staining due to formaldehyde. In the active stage of the disease the increase in number of mast cells was significant. Their pronounced degranulation was evident in both semi- and ultrathin preparations. Two forms of degranulation were distinguished: 1. by the release of granules; 2. by the extrusion of whole cytoplasmic areas. The latter indicated fast degranulation, in accordance with observations in animal experiments. Mast cells became closely related to the capillaries, Schwann-cells and nerve fibres of the lamina propria, with myofibroblasts and collagenous fibres. At some places they were found between the epithelial cells of Lieberkühn's crypts. It is assumed that this close topographical correlation represents also functional connections. The present morphological findings corroborate current hypotheses and suggest that the increase in number of mast cells in the active stage of coliitis ulcerosa mediates an hyperergic reaction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Balázs, G Illyés, G Vadász. 1989. [Mast cells in ulcerative colitis].. https://pubmed.ncbi.nlm.nih.gov/2797015/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.

Ulcerative colitis (UC) is characterized by impairment of the epithelial barrier and the formation of ulcer-type lesions, which result in local leaks and generalized alterations of mucosal tight junctions. Ultimately, this results in increased basal permeability. Although disruption of the epithelial barrier in the gut is a hallmark of inflammatory bowel disease and intestinal infections, it remains unclear whether barrier breakdown is an initiating event of UC or rather a consequence of an underlying inflammation, evidenced by increased production of proinflammatory cytokines. UC is less common in smokers, suggesting that the nicotine in cigarettes may ameliorate disease severity. The mechanism behind this therapeutic effect is still not fully understood, and indeed it remains unclear if nicotine is the true protective agent in cigarettes. Nicotine is metabolized in the body into a variety of metabolites and can also be degraded to form various breakdown products. It is possible these metabolites or degradation products may be the true protective or curative agents. A greater understanding of the pharmacodynamics and kinetics of nicotine in relation to the immune system and enhanced knowledge of gut permeability defects in UC are required to establish the exact protective nature of nicotine and its metabolites in UC. This review suggests possible hypotheses for the protective mechanism of nicotine in UC, highlighting the relationship between gut permeability and inflammation, and indicates where in the pathogenesis of the disease nicotine may mediate its effect.

Colitis, Ulcerative↗